Although the nondegradative effects of Fbxo7-mediated ubiquitination of PFKP in T cells remain to be elucidated, we hypothesize an essential role for Fbxo7 in cancer cell lines in blood lineages is as an activator of Cdk6. Here, FBXO7 is linked to cancer.